NIH trial: Remdesivir works best in COVID patients on oxygen
The US National Institutes of Health (NIH) on Friday said that data from its trial of Gilead Sciences Inc’s remdesivir show that the drug offers the most benefit ...Details
Thai researcher eyes affordable, accessible coronavirus vaccine for SE Asia
A researcher leading Thailand’s push to manufacture a coronavirus vaccine says its aim is to make it cost-effective and accessible to Southeast Asia, and play a ...Details
‘Poor countries should boost local pharmaceutical production’
COVID-19 outbreak has heightened the need to boost pharmaceutical production in poor countries as lack of access to essential medicines is a tragic reality for many families ...Details
GP completes handover of 50,000 PPE
As a part of Grameenphone’s COVID-19 responses to support the nation, the company has completed the distributon of 50,000 sets of medical-grade full set professional ...Details
Coronavirus infection rate may shift toward younger ages
The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness ...Details
